Literature DB >> 12737947

The orchestration of body iron intake: how and where do enterocytes receive their cues?

David M Frazer1, Gregory J Anderson.   

Abstract

Our understanding of how iron transverses the intestinal epithelium has improved greatly in recent years, although the mechanism by which body iron demands regulate this process remains poorly understood. By critically examining the earlier literature in this field and considering it in combination with recent advances we have formulated a model explaining how iron absorption could be regulated by body iron requirements. In particular, this analysis suggests that signals to alter absorption exert a direct effect on mature enterocytes rather than influencing the intestinal crypt cells. We propose that the liver plays a central role in the maintenance of iron homeostasis by regulating the expression of hepcidin in response to changes in the ratio of diferric transferrin in the circulation to the level of transferrin receptor 1. Such changes are detected by transferrin receptor 2 and the HFE/transferrin receptor 1 complex. Circulating hepcidin then directly influences the expression of Ireg1 in the mature villus enterocytes of the duodenum, thereby regulating iron absorption in response to body iron requirements. In this manner, the body can rapidly and appropriately respond to changes in iron demands by adjusting the release of iron from the duodenal enterocytes and, possibly, the macrophages of the reticuloendothelial system. This model can explain the regulation of iron absorption under normal conditions and also the inappropriate absorption seen in pathological states such as hemochromatosis and thalassemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737947     DOI: 10.1016/s1079-9796(03)00039-1

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  42 in total

1.  Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis.

Authors:  D M Frazer; H R Inglis; S J Wilkins; K N Millard; T M Steele; G D McLaren; A T McKie; C D Vulpe; G J Anderson
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 2.  Recent advances in intestinal iron transport.

Authors:  Gregory J Anderson; David M Frazer
Journal:  Curr Gastroenterol Rep       Date:  2005-10

3.  Association between maternal iron supplementation during pregnancy and risk of celiac disease in children.

Authors:  Ketil Størdal; Margaretha Haugen; Anne Lise Brantsæter; Knut E A Lundin; Lars C Stene
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-07       Impact factor: 11.382

4.  Circulating gastrin is increased in hemochromatosis.

Authors:  Kelly A Smith; Suzana Kovac; Gregory J Anderson; Arthur Shulkes; Graham S Baldwin
Journal:  FEBS Lett       Date:  2006-10-18       Impact factor: 4.124

5.  Normal iron metabolism and the pathophysiology of iron overload disorders.

Authors:  Chiang W Siah; John Ombiga; Leon A Adams; Debbie Trinder; John K Olynyk
Journal:  Clin Biochem Rev       Date:  2006-02

6.  Changes in the expression of intestinal iron transport and hepatic regulatory molecules explain the enhanced iron absorption associated with pregnancy in the rat.

Authors:  K N Millard; D M Frazer; S J Wilkins; G J Anderson
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 7.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.

Authors:  T Kelleher; E Ryan; S Barrett; M Sweeney; V Byrnes; C O'Keane; J Crowe
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

9.  The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes.

Authors:  Pauline Lee; Hongfan Peng; Terri Gelbart; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.